JP2008521926A5 - - Google Patents

Download PDF

Info

Publication number
JP2008521926A5
JP2008521926A5 JP2007544521A JP2007544521A JP2008521926A5 JP 2008521926 A5 JP2008521926 A5 JP 2008521926A5 JP 2007544521 A JP2007544521 A JP 2007544521A JP 2007544521 A JP2007544521 A JP 2007544521A JP 2008521926 A5 JP2008521926 A5 JP 2008521926A5
Authority
JP
Japan
Prior art keywords
composition
mannitol
group
carbomer
edetate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007544521A
Other languages
English (en)
Japanese (ja)
Other versions
JP4968844B2 (ja
JP2008521926A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/043545 external-priority patent/WO2006060618A2/en
Publication of JP2008521926A publication Critical patent/JP2008521926A/ja
Publication of JP2008521926A5 publication Critical patent/JP2008521926A5/ja
Application granted granted Critical
Publication of JP4968844B2 publication Critical patent/JP4968844B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2007544521A 2004-12-02 2005-12-02 局所用ネパフェナク処方物 Expired - Lifetime JP4968844B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63256204P 2004-12-02 2004-12-02
US60/632,562 2004-12-02
PCT/US2005/043545 WO2006060618A2 (en) 2004-12-02 2005-12-02 Topical nepafenac formulations

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011257966A Division JP2012041368A (ja) 2004-12-02 2011-11-25 局所用ネパフェナク処方物

Publications (3)

Publication Number Publication Date
JP2008521926A JP2008521926A (ja) 2008-06-26
JP2008521926A5 true JP2008521926A5 (cg-RX-API-DMAC7.html) 2008-10-30
JP4968844B2 JP4968844B2 (ja) 2012-07-04

Family

ID=35848959

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007544521A Expired - Lifetime JP4968844B2 (ja) 2004-12-02 2005-12-02 局所用ネパフェナク処方物
JP2011257966A Withdrawn JP2012041368A (ja) 2004-12-02 2011-11-25 局所用ネパフェナク処方物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011257966A Withdrawn JP2012041368A (ja) 2004-12-02 2011-11-25 局所用ネパフェナク処方物

Country Status (23)

Country Link
US (3) US7834059B2 (cg-RX-API-DMAC7.html)
EP (1) EP1819362B1 (cg-RX-API-DMAC7.html)
JP (2) JP4968844B2 (cg-RX-API-DMAC7.html)
KR (1) KR101289661B1 (cg-RX-API-DMAC7.html)
CN (1) CN101068573A (cg-RX-API-DMAC7.html)
AR (1) AR052252A1 (cg-RX-API-DMAC7.html)
AT (1) ATE476200T1 (cg-RX-API-DMAC7.html)
AU (1) AU2005311738B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0518904B1 (cg-RX-API-DMAC7.html)
CA (1) CA2586807C (cg-RX-API-DMAC7.html)
CY (1) CY1110780T1 (cg-RX-API-DMAC7.html)
DE (1) DE602005022756D1 (cg-RX-API-DMAC7.html)
DK (1) DK1819362T3 (cg-RX-API-DMAC7.html)
ES (1) ES2348249T3 (cg-RX-API-DMAC7.html)
MX (1) MX2007006558A (cg-RX-API-DMAC7.html)
PL (1) PL1819362T3 (cg-RX-API-DMAC7.html)
PT (1) PT1819362E (cg-RX-API-DMAC7.html)
RU (1) RU2007124638A (cg-RX-API-DMAC7.html)
SI (1) SI1819362T1 (cg-RX-API-DMAC7.html)
TW (1) TWI358290B (cg-RX-API-DMAC7.html)
UY (1) UY29238A1 (cg-RX-API-DMAC7.html)
WO (1) WO2006060618A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200704763B (cg-RX-API-DMAC7.html)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI358290B (en) 2004-12-02 2012-02-21 Alcon Inc Topical nepafenac formulations
SI1885336T1 (sl) * 2005-05-10 2009-08-31 Alcon Inc Suspenzijske formulacije, ki obsegajo aktivno sestavino, poloksamerni ali meroksapolni surfaktant in glikol, in njihova uporaba za pripravo zdravila za zdravljenje oftalmičnih motenj
AU2006244245B2 (en) * 2005-05-10 2010-11-18 Alcon, Inc. Ophthalmic suspension comprising an ophthalmic drug, a poloxamine and a glycol tonicity-adjusting agent, use of said composition for the manufacture of a medicament for treating ophthalmic disorders
TW200812575A (en) * 2006-04-28 2008-03-16 Alcon Inc Formulations containing amide derivatives of carboxylic acid NSAIDs for topical administration to the eye
US20080057022A1 (en) * 2006-08-30 2008-03-06 Erning Xia Ophthalmic Pharmaceutical Compositions and Uses Thereof
CN101754748A (zh) * 2007-05-24 2010-06-23 阿西克斯医疗公司 治疗干眼症的制剂和方法
TWI531362B (zh) * 2008-07-21 2016-05-01 艾爾康股份有限公司 具有治療劑遞送能力之眼科裝置
TW201023912A (en) * 2008-12-05 2010-07-01 Alcon Res Ltd Pharmaceutical suspension
US8912236B2 (en) * 2009-03-03 2014-12-16 Alcon Research, Ltd. Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (RTKi) compounds to the eye
CN105362221A (zh) * 2009-03-03 2016-03-02 爱尔康研究有限公司 向眼部递送受体酪氨酸激酶抑制性(RTKi)化合物的药物组合物
HUE038821T2 (hu) 2009-12-03 2018-11-28 Novartis Ag Karboxivinil polimert tartalmazó nanorészecske szuszpenziók
US9544143B2 (en) 2010-03-03 2017-01-10 Duo Security, Inc. System and method of notifying mobile devices to complete transactions
US9532222B2 (en) 2010-03-03 2016-12-27 Duo Security, Inc. System and method of notifying mobile devices to complete transactions after additional agent verification
US9467463B2 (en) 2011-09-02 2016-10-11 Duo Security, Inc. System and method for assessing vulnerability of a mobile device
CN104114154A (zh) * 2011-12-16 2014-10-22 阿勒根公司 包含聚乙烯基己内酰胺-聚乙酸乙烯酯-聚乙二醇接枝共聚物(Soluplus)的眼用组合物
WO2014207769A1 (en) 2013-06-27 2014-12-31 Mylan Laboratories Ltd Process for the preparation of nepafenac
CN104490861A (zh) * 2014-11-21 2015-04-08 三明欣茂药业有限公司 一种缓释型奈帕芬胺眼用制剂
HUE048564T2 (hu) 2015-01-26 2020-08-28 Bausch & Lomb Szemészeti szuszpenzió készítmény
US9930060B2 (en) 2015-06-01 2018-03-27 Duo Security, Inc. Method for enforcing endpoint health standards
CN107024550A (zh) * 2016-12-21 2017-08-08 广州仁恒医药科技股份有限公司 奈帕芬胺眼用药物组合物的质控方法
CN106963730A (zh) * 2016-12-22 2017-07-21 广州仁恒医药科技股份有限公司 高度稳定的奈帕芬胺眼用药物组合物
US10412113B2 (en) 2017-12-08 2019-09-10 Duo Security, Inc. Systems and methods for intelligently configuring computer security
US11658962B2 (en) 2018-12-07 2023-05-23 Cisco Technology, Inc. Systems and methods of push-based verification of a transaction
IT201900000561A1 (it) * 2019-01-14 2020-07-14 Medivis S R L Formulazioni topiche oftalmiche chimicamente e fisicamente stabili a base di Nepafenac
JP6994061B2 (ja) * 2019-02-15 2022-01-14 ノバルティス アーゲー 4-(7-ヒドロキシ-2-イソプロピル-4-オキソ-4h-キナゾリン-3-イル)-ベンゾニトリルの製剤
CN114272207B (zh) * 2022-01-21 2023-04-11 山东诺明康药物研究院有限公司 一种纳米晶混悬滴眼液及其制备方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1226344A (cg-RX-API-DMAC7.html) 1967-07-31 1971-03-24
CH577461A5 (cg-RX-API-DMAC7.html) 1975-08-13 1976-07-15 Robins Co Inc A H
US4313949A (en) 1979-09-26 1982-02-02 A. H. Robins Company, Inc. Method of producing an inhibitory effect on blood platelet aggregation
US4254146A (en) 1979-10-18 1981-03-03 A. H. Robins Company, Inc. 3-Benzoyl-2-nitrophenylacetic acids, metal salts, amides and esters
IL61945A (en) 1980-02-19 1984-09-30 Robins Co Inc A H 2-amino-3-(hydroxy(phenyl)methyl)phenylacetic acids,esters and amides and pharmaceutical compositions containing them
US4503073A (en) 1981-01-07 1985-03-05 A. H. Robins Company, Incorporated 2-Amino-3-(alkylthiobenzoyl)-phenylacetic acids
IL64724A0 (en) 1981-02-17 1982-03-31 Robins Co Inc A H 2-amino-3-(halobenzoyl)-methylphenylacetic acids and esters and salts thereof and pharmaceutical compositions containing them
US4568695A (en) 1983-12-07 1986-02-04 A. H. Robins Company, Incorporated 2-Amino-3-benzoyl-phenethylalcohols and intermediates therefor
US4851443A (en) 1985-03-14 1989-07-25 Smith Kline Dauelsberg, Gmbh Carboxylic acid amides, compositions and medical use thereof
EP0195582B1 (en) 1985-03-14 1990-01-24 SMITH KLINE DAUELSBERG GmbH 5-aminosalicylic acid derivatives of non-steroidal antiinflammatory acids
US4683242A (en) 1985-10-28 1987-07-28 A. H. Robins Company, Incorporated Transdermal treatment for pain and inflammation with 2-amino-3-aroylbenzeneacetic acids, salts and esters
DK406686D0 (da) 1986-08-26 1986-08-26 Hans Bundgaard Carboxylsyrederivater
US4910225A (en) 1988-01-27 1990-03-20 Senju Pharmaceutical Co., Ltd. Locally administrable therapeutic composition for inflammatory disease
US5461081A (en) 1989-09-28 1995-10-24 Alcon Laboratories, Inc. Topical ophthalmic pharmaceutical vehicles
US5521222A (en) 1989-09-28 1996-05-28 Alcon Laboratories, Inc. Topical ophthalmic pharmaceutical vehicles
US5624893A (en) 1993-10-14 1997-04-29 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment of the cornea following laser irradiation
US5475034A (en) 1994-06-06 1995-12-12 Alcon Laboratories, Inc. Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders
US6066671A (en) * 1997-12-19 2000-05-23 Alcon Laboratories, Inc. Treatment of GLC1A glaucoma with 3-benzoyl-phenylacetic acids, esters, or amides
AR030346A1 (es) * 2000-08-14 2003-08-20 Alcon Inc Metodo de tratamiento de desordenes neurodegenerativos de la retina y cabeza de nervio optico
AR030345A1 (es) * 2000-08-14 2003-08-20 Alcon Inc Metodo de tratamiento de desordenes relacionados con angiogenesis
PL373787A1 (en) * 2002-05-03 2005-09-19 Alcon Inc. Method of treating vascular endothelial growth factor mediated vascular disorders using amfenac or nepafenac
WO2004064828A1 (ja) 2003-01-21 2004-08-05 Senju Pharmaceutical Co., Ltd. 2−アミノ−3−(4−ブロモベンゾイル)フェニル酢酸含有水性液剤
TWI358290B (en) 2004-12-02 2012-02-21 Alcon Inc Topical nepafenac formulations

Similar Documents

Publication Publication Date Title
RU2007124638A (ru) Препараты непафенака для местного применения
JP2008540532A5 (cg-RX-API-DMAC7.html)
JP2011522086A5 (cg-RX-API-DMAC7.html)
JP2006510414A5 (cg-RX-API-DMAC7.html)
JP2008540532A (ja) 活性成分、ポロキサマー界面活性剤もしくはメロキサポール界面活性剤およびグリコールを含有する懸濁処方物、ならびに眼の障害を処置するための医薬の製造のためのその使用
JP2005504804A5 (cg-RX-API-DMAC7.html)
CA2395424A1 (en) Methods of using polyphosphates to decrease erosive potential of acidic beverages
US20050282715A1 (en) Use of multifunctional surface active agents to clean contact lenses
CN1748024A (zh) 保护眼组织膜完整性的隐形眼镜护理组合物、应用和制备方法
JP2004522993A5 (cg-RX-API-DMAC7.html)
CA2431437A1 (en) Lens care product containing dexpanthenol
JP2005520779A5 (cg-RX-API-DMAC7.html)
JP2006501225A5 (cg-RX-API-DMAC7.html)
RU96101722A (ru) Состав для кислотной обработки призабойной зоны пласта
JP2003034643A5 (cg-RX-API-DMAC7.html)
JP2010518075A5 (cg-RX-API-DMAC7.html)
JP2008540847A5 (cg-RX-API-DMAC7.html)
JP2005508248A5 (cg-RX-API-DMAC7.html)
WO2004014443A3 (fr) Solution de rincage pour lentilles de contact
JP2005054091A (ja) 洗浄剤組成物
RU2007112375A (ru) Раствор для травления титановых сплавов
WO2005025560A1 (ja) 眼科用組成物
DK1438961T3 (da) Bioækvivalent sammensætning af itraconazol dispergeret i en hydrofil polymer